Skip to main content
A Better Partnership

Joscelyn (Josie) Cekola Boucher

Executive Partner | Email

  • Kalamazoo

    t. +

    f. +


Josie Boucher’s practice focuses on corporate and securities law, with an emphasis on representing emerging growth companies in all stages of development. She counsels clients on a variety of business transactions, such as venture capital financing, private placements, strategic alliances, research and development, technology licensing and acquisition, international business, clinical and pre-clinical study agreements, and supply, distribution and manufacturing contracts. Josie also represents venture capital funds in connection with fundraising, investment and other transactions. Her responsive and efficient nature positions her as a valuable team member to the firm’s Corporate Services Practice Group and clients. Josie tailors her strategy to each organization’s goals and enjoys being an integral part of business planning, from inception to exit. Josie is the Executive Partner for Warner's Kalamazoo Office and chair of the firm's Funds and Investments Services Practice Group.


  • University of Michigan Law School J.D.
  • University of Michigan A.B. Ed. with distinction


  • Michigan


  • U.S. Court of Appeals, Sixth Circuit
  • U.S. District Court, Eastern District of Michigan

Bar Associations

  • American Bar Association
  • State Bar of Michigan
  • Kalamazoo Bar Association


  • Advises clients on transaction structure, strategy and general legal matters
  • Represented a cancer therapeutic development company in a various series of convertible note  and preferred stock financings, culminating in a $60M Series D financing round, and ultimate initial public offering
  • Represented a medical device company in an $8 million Series A preferred stock financing
  • Represented a cancer diagnostic company in a $2 million convertible debt offering and $5 million Series A financing
  • Represented a dental medical device company in a $4 million Series A preferred stock financing
  • Represented a biomedical company in the conversion of the company from a limited liability company to a corporation and subsequent $5 million Series A preferred stock financing
  • Represented an agricultural biotechnology company in various series of convertible note and preferred stock financings, including a $18 million Series D preferred stock financing
  • Represented a biotech company in a $1 million common stock financing 
  • Represented a drug development company in its conversion from a corporation into a limited liability company and $32.5 million Series D preferred equity financing
  • Represented a drug development company in the spin out of an asset and subsequent $20 million Series A-1 preferred stock financing and $40 million Series A-2 preferred stock financing 
  • Represented a clinical stage biopharmaceutical company in its initial public offering
  • Represented a $20 million venture capital fund in fund formation and investment matters
  • Represented a private equity fund with over $1 billion in capital under management in various growth capital investments in emerging growth companies
  • Represented a family office in preferred equity investments in innovative food companies
  • Negotiated a License Agreement on behalf of a cancer therapeutic drug development company with a publicly traded biotechnology company
  • Negotiated a cross-license agreement on behalf of a cardiac monitoring device company with a Fortune 500 medical device company
  • Negotiated a license agreement on behalf of a biotechnology company with an Indian manufacturer of xylitol
  • Negotiated distribution and manufacturing agreements on behalf of a publicly traded cardiac medical device company
  • Negotiated a collaboration agreement on behalf of an agricultural biotechnology company with multinational publicly traded agrochemical and agricultural biotechnology company
  • Negotiated a toll manufacturing agreement on behalf of an agricultural biotechnology company with an Italian manufacturer
  • Represented a media company in its acquisitions of an Indian-based internet company and a venture-backed internet company for automotive enthusiasts
  • Represented a media company in acquisition of a specialty newspaper line and magazine  
  • Represented an aftermarket automotive parts supplier in numerous acquisitions and divestures
  • Represented and advised a Fortune 500 publicly traded company in connection with internal international restructuring transactions

Honors & Awards

  • Best Lawyers in America, Securities/Capital Markets Law, 2020-Present
  • Michigan Super Lawyer Rising Star, 2009-15
  • Michigan Lawyers Weekly 2019 "Women in the Law”


Speaking Engagements

  • "Show Me the Money! Raising Funds for Startups," Innovation Lunch-and-Learn Series, April 24, 2019, Kalamazoo, Michigan
  • "Financing Your Start-Up: Venture Capital Basics," Innovation Lunch-and-Learn Series, April 19, 2018, Kalamazoo, Michigan

NOTICE. Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you.

By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you.

Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.



+ -